The global semen analysis market revenue was around US$ 998.4 million in 2022 and is estimated to reach US$ 1,483.7 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period from 2023 to 2031.
Semen analysis is the term utilized for the laboratory techniques and methods that are performed to measure sperm parameters, including motility, number, viability, and morphology. Semen analysis is commonly performed to consider male factor infertility. A regular semen analysis should include the physical characteristics of semen (odor, color, liquefaction, and viscosity), concentration, volume, progression, morphology, and sperm motility.
Market Driving Factors
The growing incidence of male infertility is a key driver of the semen analysis market. This is mainly owing to elements like hormonal imbalances, lifestyle changes, genetic disorders, and environmental pollution that contribute to male infertility, necessitating semen analysis for proper diagnosis.
Advancements in diagnostic techniques like Computer-assisted sperm analysis (CASA) are estimated to drive the market growth. This technology offers automated semen analysis. This technology enables exact and objective assessment of sperm parameters, enhancing the reliability and efficiency of the analysis.
The increasing awareness about fertility treatments and the availability of several assisted reproductive technologies have contributed to the boosting demand for the semen analysis market. In addition, fertility clinics and Anti-retroviral Therapy (ART) centers broadly utilize semen analysis to suggest treatment alternatives, such as intrauterine insemination (IUI), In vitro fertilization (IVF), and intracytoplasmic sperm injection (ICSI).
The scarcity of knowledge about semen analysis in economically poor nations is hampering the market growth.
Regional Analysis
Asia-Pacific dominated the market in terms of revenue and is estimated to maintain its dominance. This can be attributed to the raised in infertility cases and the surge in awareness regarding semen analysis testing among the population.
Europe is estimated to dominate the market in terms of the growth rate. This is due to the existence of a higher number of infertility centers, an increase in investment in healthcare, and a surge in awareness about healthcare technologies among Europeans.
Segmentation Insights
Product Insight
The disposable and consumable segment dominated the market in terms of the largest share and is predicted to continue its dominance during the projection period. This can be attributed to their limited durability and growth in the adoption of consumables & disposable during semen analysis testing.
Age Group Insight
The 41 and greater than 41 years segment dominated the market in terms of revenue and is estimated to maintain its dominance. This can be majorly attributed to the surge in the prevalence of infertility in ages between 41 and greater than 41 years.
End User Insight
The fertility centers segment dominates the market in terms of the largest share during the forecast period. This is due to the surge in the number of infertility rates of the population, and the surge in IVF procedures and vasectomy performed in fertility centers.
Prominent Companies
Segmentation Outline
The global semen analysis market segmentation focuses on the Product, Age Group, End User, and Region.
By Product
By Age Group
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL SEMEN ANALYSIS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: SEMEN ANALYSIS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL SEMEN ANALYSIS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL SEMEN ANALYSIS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 SEMEN ANALYZERS
5.2.1 MANUAL SEMEN ANALYZERS
5.2.2 AUTOMATED SEMEN ANALYZERS
5.3 CENTRIFUGES FOR SAMPLE PREPARATION
5.4 SEMEN TEST KITS
5.5 DISPOSABLES AND CONSUMABLES
5.6 SOFTWARE
6 GLOBAL SEMEN ANALYSIS MARKET, BY AGE GROUP
6.1 OVERVIEW
6.2 34 AND BELOW 34 YEARS
6.3 35-40 YEARS
6.4 41 AND GREATER THAN 41 YEARS
7 GLOBAL SEMEN ANALYSIS MARKET, BY END USER
7.1 OVERVIEW
7.2 FERTILITY CENTERS
7.3 HOSPITALS
7.4 DIAGNOSTIC LABORATORIES
7.5 OTHERS
8 GLOBAL SEMEN ANALYSIS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL SEMEN ANALYSIS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 ANDROFERT
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 BIOLINE TECHNOLOGIES
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 MIDLAND FERTILITY
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 NW CRYOBANK
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 DNA DIAGNOSTICS CENTER INC
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 HAMILTON THORNE INC.
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 LAB IVF
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 MICHIGAN CENTER FOR FERTILITY & WOMEN'S HEALTH
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 ARQUIMEA
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 SYNERGY MEDICAL SYSTEMS
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.11 MICROPTIC SL
10.11.1 OVERVIEW
10.11.2 FINANCIAL PERFORMANCE
10.11.3 PRODUCT OUTLOOK
10.11.4 KEY DEVELOPMENTS
10.11.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.12 LEJA PRODUCTS B.V.
10.12.1 OVERVIEW
10.12.2 FINANCIAL PERFORMANCE
10.12.3 PRODUCT OUTLOOK
10.12.4 KEY DEVELOPMENTS
10.12.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.13 COOPER COMPANIES INC
10.13.1 OVERVIEW
10.13.2 FINANCIAL PERFORMANCE
10.13.3 PRODUCT OUTLOOK
10.13.4 KEY DEVELOPMENTS
10.13.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.14 MOTILITYCOUNT APS
10.14.1 OVERVIEW
10.14.2 FINANCIAL PERFORMANCE
10.14.3 PRODUCT OUTLOOK
10.14.4 KEY DEVELOPMENTS
10.14.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.15 SPERM PROCESSOR
10.15.1 OVERVIEW
10.15.2 FINANCIAL PERFORMANCE
10.15.3 PRODUCT OUTLOOK
10.15.4 KEY DEVELOPMENTS
10.15.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.16 FLOWLABS
10.16.1 OVERVIEW
10.16.2 FINANCIAL PERFORMANCE
10.16.3 PRODUCT OUTLOOK
10.16.4 KEY DEVELOPMENTS
10.16.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.17 MEDICAL ELECTRONICS SYSTEMS
10.17.1 OVERVIEW
10.17.2 FINANCIAL PERFORMANCE
10.17.3 PRODUCT OUTLOOK
10.17.4 KEY DEVELOPMENTS
10.17.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved